Cytek BioSciences Inc
Research Cytek BioSciences Inc (CTKB) on Bullrun: market cap USD 560.48M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCTKB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 560.48M
- Financial periodFY2025
- RevenueUSD 201.49M
- Revenue growth0.5%
- Net income-USD 66.54M
- Free cash flow-USD 8.77M
- Gross margin51.8%
Valuation Snapshot
latest market cap is USD 560.48M.
About Cytek BioSciences Inc
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers;
Frequently asked questions
What is Cytek BioSciences Inc's market cap?
Cytek BioSciences Inc's market capitalization is USD 560.48M.
What does Cytek BioSciences Inc do?
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis;